Title: Circadian Rhythm Sleep Disorders Herbert Yue, MD Stanford
1Circadian Rhythm Sleep Disorders
- Herbert Yue, MD
- Stanford Sleep Medicine Center
2Introduction
- Two modular processes that govern sleep and
wakefulness - Referred to as two process model of sleep wake
regulation - Homeostatic drive for sleep
- Intrinsic circadian rhythm
- For each hour of wakefulness, homeostatic drive
for sleep increases - Typically after 14-16 hours, sufficient
homeostatic sleep drive is obtain
3Introduction
- Circadian rhythm important regulator of
wakefulness - Allows synchronization of physiologic process to
desired sleep wake cycle - Exerts active promotion of wakefulness
4Introduction
5Circadian Rhythm Biology
- Circadian rhythms generated from superchiasmatic
nucleus (SCN) of hypothalamus - Signals from SCN modulate daily rhythms in sleep
and alertness - Core body temperature
- Secretion of cortisol and melatonin
- Intrinsic rhythm of clock slightly longer than 24
hours - Synchronization occurs to 24hr schedule using
external cues - Zeitgeibers Temporal timing signals, light
exposure
6Circadian Rhythm Biology
- Photoreceptors in retina important signal
collectors - Receptors discovered in cells of retina
- Important for entrainment
- Contain photopigment melanopsin
- Most sensitive to blue wavelength of light
7Circadian Rhythm Biology
8Circadian Phase Markers
- Active investigation into markers of circadian
phase in humans - ?Clinical utility of markers
- Two currently utilized markers
- Core body temperature
- Dim light melatonin measurement (DLMO)
9Core Body temperature
- Drop in temp associated with stability in sleep
- Three dips in temp
- 800pm-1200am
- 300-500am
- 100-400pm
10Melatonin Secretion
- Increase in levels around 800pm
- Levels peak at approximately 300am and begin to
decrease - Lowest levels just before awakening
11Circadian Phase Markers
- Measurement of markers difficult
- Core body temperature altered by activity, food
intake, and sleep - Melatonin secretion very sensitive to light
exposure, needs to be obtained under dim light
conditions - Dim light melatonin onset (DLMO)
12Circadian Rhythm
- Disruptions in the circadian rhythm physiology
consequently can cause a number of circadian
rhythm sleep disorders - Disorders can be secondary to external inference
with sleep wake mechanism - Remainder of disorders are related to inherent
disruption of the circadian rhythm
13Classification
- Six distinct circadian rhythm disorders
recognized by the International Classification of
Sleep Disorders (ICSD-2) - Essential feature Persistent/recurrent pattern
of sleep disturbance - Alterations in circadian timekeeping system
- Misalignment between internal circadian timing
and exogenous influences
14Classification
- Diagnostic criteria require impairment
- Social, occupational, etc
- Phase tolerance may exist i.e. sleep not
disrupted by sleep alignment - Diagnosis also must not be better explained by
other sleep disorder - Unconventional sleep cycle ? CRSD
- Persistent insomnia no matter timing of sleep
- Congruence of sleep timing and circadian rhythm
15Classification
- Six distinct CRSDs
- Delayed sleep phase disorder
- Advanced sleep phase disorder
- Jet lag type
- Shift work type
- Irregular sleep wake cycle disorder
- Free running type
- ICSD also recognizes CRSD NOS
- Secondary to medical condition, etc
16Prevalence
- Exact prevalence not known, although high numbers
if shift workers/travelers considered - One formal study using diagnostic criteria with
epidemiologic sample looked at SWD - 30 of night workers and 26 of rotating workers
met minimal criteria for SWD - Little data for other CRSDs
17Common Themes
- All dxs require 2 week actigraphy/sleep diary
- Goal is to create congruence
- Treatment
- Light in AM backward shift and vice versa
- Melatonin works in opposite manner from light
- Light, exercise in periods of activity
18Shift Work Disorder (SWD)
- Minimal criteria for diagnosis
- Work in shift work position, either night-shift
or rotating shift for the past 2 weeks - Impairment in daytime functioning, typically
insomnia or excessive daytime sleepiness, present
for gt 1 month
19Shift Work Disorder (SWD)
20Shift Work Disorder (SWD)
21Shift Work Disorder (SWD)
22Shift Work Disorder (SWD)
- Rotating shift workers show increased rates of
impairment - gt30 of rotating shift workers with reported
sleep latencies of greater than 30 minutes
compared to 10 of night and day shift workers - Increased rates of absenteeism, accidents at work
and poor job satisfaction
23Shift Work Disorder (SWD)
- Risk factors for SWD
- Increasing age peak in sleep disturbances at age
52 with decreases after age 62 - Female gender women with less sleep on average
then men and increase complaints - Intrinsic tolerance of individuals
24Shift Work Disorder (SWD)
- Non-pharmacologic treatment
- Sleep hygiene
- Scheduled naps
- Assessment of work schedule
- Exercise
- Light exposure
25Shift Work Disorder (SWD)
- Pharmacologic treatments include
modafinil/stimulants - Only modafinil or armodafinil currently FDA
approved as tx for SWD - Improvements in self reported sleepiness,
objective sleep latencies, and accident rates - Other stimulants, such as amphetamines not
indicated - Rebound insomnia
26Delayed Sleep Phase Disorder (DSPD)
- Characterized as bedtimes that are 3-6 hours
later than conventional times - Typically problems sleeping before 200am and
waking up earlier than 1000am - Subjective sleepiness worst in the mornings, with
highest levels of alertness during the late
evening
27Delayed Sleep Phase Disorder (DSPD)
- Difficulty with sleep onset at desired time, but
sleep once initiated is normal - Most common CRSD referral, although population
data lacking - Population estimates of prevalence of 0.17
- Prevalence increases to gt15 amongst adolescents
- Positive family history
28Delayed Sleep Phase Disorder (DSPD)
29Delayed Sleep Phase Disorder (DSPD)
- Most patients present for treatment as they are
unable to conform to societal bed/wake times - Treatment primarily light exposure and melatonin
administration
30Delayed Sleep Phase Disorder (DSPD)
- Bright light therapy generally given in the early
morning for 1-2 hours - Induces phase shift backwards
- Typically takes upwards of 2 weeks to see effects
- Compliance often limited
31Melatonin Secretion
32Delayed Sleep Phase Disorder (DSPD)
- Melatonin may also be given, typically 5-7 hours
before the DLMO - DLMO typically occurs 2-3 hours before sleep
onset in healthy individuals - Effects of melatonin may not be long lived
- Some studies show reversion to DSPD after
medication stopped
33Advanced Sleep Phase Disorder (ASPD)
- Habitual and undesired sleep/wake up times
several hours earlier than desired - Sleep onset 600-900pm and wake up times
200-500am - Symptoms of early morning awakenings, sleep
maintenance problems, or excessive daytime
sleepiness
34Advanced Sleep Phase Disorder (ASPD)
- Associated with increasing age
- Non age associated cases rare
- Prevalence approx 1 of middle aged adults
- Genetic markers identified, ?autosomal dominant
transmission - -Missense mutation in Period 2 gene
35Advanced Sleep Phase Disorder (ASPD)
- Treatment typically light exposure in early
evening - Usually in the hours of 700-900pm
- Delays DLMO
- Compliance limited in the few studies performed
- No current role for hypnotics or stimulants
36Melatonin Secretion
37Jet Lag Disorder (JLD)
- Defined as disruption in sleep after travel
across 2-3 time zones - Typically benign and self limited, although can
be distressing to patients productivity - Circadian rhythm resets
- Approx 90 minutes later for westward flights
- 60 minutes earlier for eastward flights
- Treatment typically involves
- Light administration
- Melatonin administration
38Jet Lag Disorder (JLD)
- Treatment with light or melatonin usually
involves corresponding exposure - Light exposure
- Maximize exposure in the morning for westward
flights, exposure in evening for eastward flight - Melatonin admin
- Most studies evaluated 5mg dose at bedtime,
typically for eastward travel
39Melatonin Secretion
40Jet Lag Disorder (JLD)
- Hypnotics
- 3-4 day course of Ambien associated with improved
sleep quality - Short acting hypnotic such as Sonata may be
helpful for an overnight flight - Armodafanil
- Recent data showing improved subjective alertness
and reduced jet lag sx - Current pending application as FDA approved
treatment for JLD
41Free Running Disorder (FRD)
- Characterized as gradual drift of major sleep
period by 1-2 hours daily - If scheduled sleep/wake times attempted, pts
report insomnia and excessive daytime sleepiness - Sx occur when non-entrained circadian rhythm out
of phase with conventional sleep/wake times - Majority of cases in the blind
- Lack of photic entrainment
- Estimated 50 have free running disorder, 70
with chronic sleep disturbances - Cases described for non-blind, usually after head
trauma
42Free Running Disorder (FRD)
43Free Running Disorder (FRD)
- Treatment in sighted individuals
- Scheduled sleep and wake cycles
- Timed bright light
- Melatonin admin
- Treatment in blind individuals
- Regular work/sleep schedule? non photic cue
- Melatonin admin (1 hr before bedtime)
44Irregular Sleep Wake Disorder (ISWD)
- Characterized as absence of clear circadian
rhythm - Although total amount of sleep normal, sleep
periods scattered throughout the day - Napping prevalent, with sleep episodes gt 3 per
day - Rare condition
- Likely secondary to primary disturbance of
circadian rhythm - Lack of external time cues, such as light and
activity - Seen most commonly in dementia, developmentally
disabled children, and with severe brain trauma
45Irregular Sleep Wake Disorder (ISWD)
46Irregular Sleep Wake Disorder (ISWD)
- Treatment primarily restoring external time cues
- Scheduled social and physical activities
- Timed bright light
- Some role for hypnotics to improve sleep
47Conclusion
- CRSD occur secondary to incongruence of sleep
time and circadian rhythm or intrinsic disruption
in circadian rhythm - Light and melatonin are useful adjuncts in tx
- Zeitgebers are critically important
- Growing literature demonstrating genetic basis
for these conditions
48(No Transcript)